bHLH–PAS proteins in cancer

Mammalian basic HLH (helix–loop–helix)–PER–ARNT–SIM (bHLH–PAS) proteins are heterodimeric transcription factors that sense and respond to environmental signals (such as pollutants) or to physiological signals (for example, hypoxia and circadian rhythms) through their two PAS domains. PAS domains form a generic three-dimensional fold, which commonly contains an internal cavity capable of small-molecule binding and outer surfaces adept at protein–protein interactions. These proteins are important in several pro-tumour and antitumour pathways and their activities can be modulated by both natural metabolites and oncometabolites. Recently determined structures and successful small-molecule screening programmes are now providing new opportunities to discover selective agonists and antagonists directed against this multitasking family of transcription factors.

[1]  W. Kaelin,et al.  Influence of Metabolism on Epigenetics and Disease , 2013, Cell.

[2]  J. Takahashi,et al.  Genetics of circadian rhythms in Mammalian model organisms. , 2011, Advances in genetics.

[3]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[4]  M. Ziegler,et al.  The NAD metabolome — a key determinant of cancer cell biology , 2012, Nature Reviews Cancer.

[5]  P. Meltzer,et al.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.

[6]  A. Wellstein,et al.  An Isoform of the Coactivator AIB1 That Increases Hormone and Growth Factor Sensitivity Is Overexpressed in Breast Cancer* , 2001, The Journal of Biological Chemistry.

[7]  M. Simon,et al.  Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Allis,et al.  Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.

[9]  K. Gardner,et al.  Regulating the ARNT/TACC3 axis: multiple approaches to manipulating protein/protein interactions with small molecules. , 2013, ACS chemical biology.

[10]  W. Porter,et al.  Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s) , 2012, Oncogene.

[11]  S. Inoue,et al.  D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. , 2012, Genes & development.

[12]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[13]  Paolo Sassone-Corsi,et al.  CLOCK-mediated acetylation of BMAL1 controls circadian function , 2007, Nature.

[14]  Patricia Keating,et al.  Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  O. Hankinson,et al.  Roles of Coactivators in Hypoxic Induction of the Erythropoietin Gene , 2010, PloS one.

[16]  P. Sassone-Corsi,et al.  Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1 , 2009, Science.

[17]  Joseph S. Takahashi,et al.  Small molecule modifiers of circadian clocks , 2012, Cellular and Molecular Life Sciences.

[18]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[19]  L. Donehower,et al.  Disrupting Circadian Homeostasis of Sympathetic Signaling Promotes Tumor Development in Mice , 2010, PloS one.

[20]  A. Sivachenko,et al.  Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.

[21]  L. Miraglia,et al.  A Functional Genomics Strategy Reveals Rora as a Component of the Mammalian Circadian Clock , 2004, Neuron.

[22]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[23]  I. Tomlinson,et al.  The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase , 2003, Annals of medicine.

[24]  S. Li,et al.  Cancer therapeutic agents targeting hypoxia-inducible factor-1. , 2011, Current medicinal chemistry.

[25]  King-Jen Chang,et al.  Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy , 2013, Proceedings of the National Academy of Sciences.

[26]  Y. Fujii‐Kuriyama,et al.  Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Brent A. Johnson,et al.  Protein‐coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy , 2011, The American journal of pathology.

[28]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[29]  Xinran Liu,et al.  Competing E3 Ubiquitin Ligases Govern Circadian Periodicity by Degradation of CRY in Nucleus and Cytoplasm , 2013, Cell.

[30]  J. Harper,et al.  SCFβ-TRCP Controls Clock-dependent Transcription via Casein Kinase 1-dependent Degradation of the Mammalian Period-1 (Per1) Proteinm* , 2005, Journal of Biological Chemistry.

[31]  J. Takahashi,et al.  Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis , 2009, Science.

[32]  W. Kaelin,et al.  Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. , 2011, Cold Spring Harbor symposia on quantitative biology.

[33]  N. Shimizu,et al.  Transcription factor single-minded 2 (SIM2) is ubiquitinated by the RING-IBR-RING-type E3 ubiquitin ligases. , 2005, Experimental cell research.

[34]  Bin Zhao,et al.  Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  G. Perdew,et al.  Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential. , 1999, Gene expression.

[36]  A. LaCroix,et al.  Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data , 2013, The Lancet.

[37]  Jiandie D. Lin,et al.  Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism , 2007, Nature.

[38]  Manoj Bhasin,et al.  Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer , 2009, Clinical Cancer Research.

[39]  L. Chodosh,et al.  HIF-2α deletion promotes Kras-driven lung tumor development , 2010, Proceedings of the National Academy of Sciences.

[40]  M. Whitelaw,et al.  The HIF1α-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element , 2009, Oncogene.

[41]  T. Noda,et al.  ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice. , 2013, Carcinogenesis.

[42]  K. Gardner,et al.  Structural basis for PAS domain heterodimerization in the basic helix–loop–helix-PAS transcription factor hypoxia-inducible factor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Sellers,et al.  High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. , 2004, Cancer cell.

[44]  Inge Jonassen,et al.  Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate Cancer , 2007, Clinical Cancer Research.

[45]  R. Verhaak,et al.  Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation , 2012, Nature.

[46]  Randy L. Johnson,et al.  Sim2 prevents entry into the myogenic program by repressing MyoD transcription during limb embryonic myogenesis , 2012, Development.

[47]  S. Becker,et al.  p160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain , 2008, Nucleic acids research.

[48]  A. Chapman-Smith,et al.  The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. , 2004, The international journal of biochemistry & cell biology.

[49]  A. Wellstein,et al.  The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. , 2008, Cancer research.

[50]  K. Kivirikko,et al.  Roles of the human hypoxia-inducible factor (HIF)-3α variants in the hypoxia response , 2011, Cellular and Molecular Life Sciences.

[51]  Satchidananda Panda,et al.  Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock , 2011, Science.

[52]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[53]  Adrian V. Lee,et al.  AIB1/SRC-3 Deficiency Affects Insulin-Like Growth Factor I Signaling Pathway and Suppresses v-Ha-ras-induced Breast Cancer Initiation and Progression in Mice , 2004, Cancer Research.

[54]  Gabriel M. Belfort,et al.  Npas4 Regulates a Transcriptional Program in CA3 Required for Contextual Memory Formation , 2011, Science.

[55]  C. Litterst,et al.  Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. , 2004, Journal of molecular biology.

[56]  Junjie Chen,et al.  Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. , 2010, Molecular cell.

[57]  R. Metz,et al.  Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκB. , 2011, Molecular endocrinology.

[58]  L. Poellinger,et al.  Redox-Regulated Recruitment of the Transcriptional Coactivators CREB-Binding Protein and SRC-1 to Hypoxia-Inducible Factor 1α , 2000, Molecular and Cellular Biology.

[59]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[60]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[61]  A. Sancar,et al.  Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase , 2010, Proceedings of the National Academy of Sciences.

[62]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[63]  P. Meltzer,et al.  In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[64]  A. Wellstein,et al.  Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Δ3 on estrogenic ligands with different intrinsic activity , 2004, Oncogene.

[65]  R. Narayanan,et al.  Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target. , 2003, Cancer letters.

[66]  B. O’Malley,et al.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family , 2009, Nature Reviews Cancer.

[67]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[68]  R. Johnson,et al.  Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression , 2007 .

[69]  Richard E Peterson,et al.  The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates. , 2008, Carcinogenesis.

[70]  K. Akashi,et al.  MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. , 2004, Cancer cell.

[71]  Paolo Sassone-Corsi,et al.  Metabolism and cancer: the circadian clock connection , 2009, Nature Reviews Cancer.

[72]  J. Lee,et al.  Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis , 2011, Proceedings of the National Academy of Sciences.

[73]  B. O’Malley,et al.  Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation , 2009, Proceedings of the National Academy of Sciences.

[74]  A. Sancar,et al.  Circadian oscillation of nucleotide excision repair in mammalian brain , 2009, Proceedings of the National Academy of Sciences.

[75]  Yuichi Makino,et al.  Inhibitory PAS Domain Protein (IPAS) Is a Hypoxia-inducible Splicing Variant of the Hypoxia-inducible Factor-3α Locus* , 2002, The Journal of Biological Chemistry.

[76]  Structure of an enclosed dimer formed by the Drosophila period protein. , 2011, Journal of molecular biology.

[77]  Rui Chen,et al.  Allosteric Inhibition of Hypoxia Inducible Factor-2 with Small Molecules , 2013, Nature chemical biology.

[78]  Han-Jong Kim,et al.  Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53. , 1999, Molecular endocrinology.

[79]  Suzanne A. Eccles,et al.  A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells , 2013, Journal of the American Chemical Society.

[80]  Padhraic Smyth,et al.  Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis , 2012, Proceedings of the National Academy of Sciences.

[81]  R. Metz,et al.  Differential Transcriptional Regulation by Mouse Single-minded 2s* , 2006, Journal of Biological Chemistry.

[82]  L. Poellinger,et al.  Definition of a Dioxin Receptor Mutant That Is a Constitutive Activator of Transcription , 2001, The Journal of Biological Chemistry.

[83]  Peter G. Schultz,et al.  High-Throughput Chemical Screen Identifies a Novel Potent Modulator of Cellular Circadian Rhythms and Reveals CKIα as a Clock Regulatory Kinase , 2010, PLoS biology.

[84]  E. McDermott,et al.  Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1 , 2004, Journal of Clinical Pathology.

[85]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[86]  T. Akiyama,et al.  Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands , 2009, Proceedings of the National Academy of Sciences.

[87]  I. Zhulin,et al.  PAS Domains: Internal Sensors of Oxygen, Redox Potential, and Light , 1999, Microbiology and Molecular Biology Reviews.

[88]  O. Hankinson.  Why does ARNT2 behave differently from ARNT? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[89]  R. Chen,et al.  Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1 , 2009, Science.

[90]  L. Poellinger,et al.  Role of the PAS Domain in Regulation of Dimerization and DNA Binding Specificity of the Dioxin Receptor , 1998, Molecular and Cellular Biology.

[91]  H. Hurst,et al.  Targeting of SWI/SNF chromatin remodelling complexes to estrogen‐responsive genes , 2002, The EMBO journal.

[92]  J. Takahashi,et al.  Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening , 2011, Proceedings of the National Academy of Sciences.

[93]  L. Huang,et al.  The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression , 2006 .

[94]  Kun-Liang Guan,et al.  Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.

[95]  M. Whitelaw,et al.  Differential Activities of Murine Single Minded 1 (SIM1) and SIM2 on a Hypoxic Response Element , 2002, The Journal of Biological Chemistry.

[96]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[97]  A. Hanberg,et al.  A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  J. Takahashi,et al.  Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[99]  R. Metz,et al.  The bHLH/PAS transcription factor singleminded 2s promotes mammary gland lactogenic differentiation , 2010, Development.

[100]  Christopher J Schofield,et al.  Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.

[101]  Florian Kreppel,et al.  SIRT1 Regulates Circadian Clock Gene Expression through PER2 Deacetylation , 2008, Cell.

[102]  O. Gotoh,et al.  Two new members of the murine Sim gene family are transcriptional repressors and show different expression patterns during mouse embryogenesis , 1996, Molecular and cellular biology.

[103]  Steven M. Reppert,et al.  Posttranslational Mechanisms Regulate the Mammalian Circadian Clock , 2001, Cell.

[104]  O. Hankinson,et al.  Recruitment of the NCoA/SRC-1/p160 Family of Transcriptional Coactivators by the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Complex , 2002, Molecular and Cellular Biology.

[105]  Jonathan W. Pillow,et al.  POSTER PRESENTATION Open Access , 2013 .

[106]  Keith Moffat,et al.  N- and C-terminal flanking regions modulate light-induced signal transduction in the LOV2 domain of the blue light sensor phototropin 1 from Avena sativa. , 2007, Biochemistry.

[107]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[108]  P. Gimotty,et al.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. , 2010, The Journal of clinical investigation.

[109]  B. O’Malley,et al.  Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. , 2005, Cancer research.

[110]  B. O’Malley,et al.  Steroid receptor coactivators 1, 2, and 3: Critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy , 2012, Molecular and Cellular Endocrinology.

[111]  Paolo Sassone-Corsi,et al.  Circadian Regulator CLOCK Is a Histone Acetyltransferase , 2006, Cell.

[112]  Christopher A Bradfield,et al.  The search for endogenous activators of the aryl hydrocarbon receptor. , 2008, Chemical research in toxicology.

[113]  K. Gardner,et al.  Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B , 2011, Proceedings of the National Academy of Sciences.

[114]  Ueli Schibler,et al.  The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian Oscillator , 2002, Cell.

[115]  Kevin H. Gardner,et al.  Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor , 2009, Proceedings of the National Academy of Sciences.

[116]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[117]  A. Veronese,et al.  Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene , 2006, Genes, chromosomes & cancer.

[118]  Joseph S. Takahashi,et al.  Circadian Mutant Overtime Reveals F-box Protein FBXL3 Regulation of Cryptochrome and Period Gene Expression , 2007, Cell.

[119]  L. Coussens,et al.  Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. , 2010, Cancer research.

[120]  Y. Fujii‐Kuriyama,et al.  SUMO Modification Regulates the Transcriptional Repressor Function of Aryl Hydrocarbon Receptor Repressor* , 2009, Journal of Biological Chemistry.

[121]  Annalisa Bordogna,et al.  New Aryl Hydrocarbon Receptor Homology Model Targeted To Improve Docking Reliability , 2011, J. Chem. Inf. Model..

[122]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[123]  J. Bass,et al.  Circadian topology of metabolism , 2012, Nature.

[124]  A. Pause,et al.  An oxygen-regulated switch in the protein synthesis machinery , 2012, Nature.

[125]  S. Panda,et al.  AMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and Degradation , 2009, Science.

[126]  K Kume,et al.  Interacting molecular loops in the mammalian circadian clock. , 2000, Science.

[127]  G. Boivin,et al.  The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. , 2010, Cancer research.

[128]  Hong Sun,et al.  Tumor and Stem Cell Biology Cancer Research Hypoxia Induces Trimethylated H 3 Lysine 4 by Inhibition of JARID 1 A Demethylase , 2010 .

[129]  M. Ittmann,et al.  Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. , 2008, Cancer Research.

[130]  R. Narayanan,et al.  Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[131]  H. Kohrt,et al.  Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor , 2013, Proceedings of the National Academy of Sciences.

[132]  L. Poellinger,et al.  Xenobiotics and Loss of Cell Adhesion Drive Distinct Transcriptional Outcomes by Aryl Hydrocarbon Receptor Signaling , 2012, Molecular Pharmacology.

[133]  G. Semenza.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics , 2010, Oncogene.

[134]  G. Semenza,et al.  Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.

[135]  Peter C. St. John,et al.  Identification of Small Molecule Activators of Cryptochrome , 2012, Science.

[136]  W. Kaelin,et al.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. , 2013, Genes & development.

[137]  Ueli Schibler,et al.  Crosstalk between components of circadian and metabolic cycles in mammals. , 2011, Cell metabolism.

[138]  J. Michaud,et al.  Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. , 2001, Human molecular genetics.

[139]  A. Harris,et al.  Targeting the hypoxia-inducible factor (HIF) pathway in cancer , 2009, Expert Reviews in Molecular Medicine.

[140]  K. Blanchard,et al.  Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. , 1998, Blood.

[141]  Hong Zhang,et al.  Crystal Structure of the Heterodimeric CLOCK:BMAL1 Transcriptional Activator Complex , 2012, Science.

[142]  Huafeng Zhang,et al.  Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization , 2009, Proceedings of the National Academy of Sciences.

[143]  M. Rubin,et al.  Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover , 2013, Proceedings of the National Academy of Sciences.

[144]  L. Guarente,et al.  SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging , 2013, Cell.

[145]  Robert C. Burghardt,et al.  Loss of Singleminded-2s in the Mouse Mammary Gland Induces an Epithelial-Mesenchymal Transition Associated with Up-Regulation of Slug and Matrix Metalloprotease 2 , 2007, Molecular and Cellular Biology.

[146]  D. Peet,et al.  Reciprocal regulation of the basic helix–loop–helix/Per–Arnt–Sim partner proteins, Arnt and Arnt2, during neuronal differentiation , 2013, Nucleic acids research.

[147]  R. Aguiar,et al.  A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. , 1998, Blood.

[148]  Yuen-Li Chung,et al.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.

[149]  Satchidananda Panda,et al.  Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ , 2012, Nature.

[150]  Jeong Hoon Kim,et al.  CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. , 2003, Molecular cell.

[151]  Y. Fujii‐Kuriyama,et al.  Dioxin receptor is a ligand-dependent E3 ubiquitin ligase , 2007, Nature.

[152]  Eduard Batlle,et al.  The circadian molecular clock creates epidermal stem cell heterogeneity , 2011, Nature.

[153]  Kathryn A. O’Donnell,et al.  A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer , 2012, Proceedings of the National Academy of Sciences.

[154]  G. Reifenberger,et al.  IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics , 2012, Nature.

[155]  M. Tang,et al.  Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.

[156]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[157]  R. A. Reid,et al.  Rev-erbα, a Heme Sensor That Coordinates Metabolic and Circadian Pathways , 2007, Science.

[158]  J. Lee,et al.  Loss of cryptochrome reduces cancer risk in p53 mutant mice , 2009, Proceedings of the National Academy of Sciences.

[159]  Peng Huang,et al.  The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.

[160]  M. Whitelaw,et al.  The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH/PAS transcription factors , 2007, FEBS letters.

[161]  J. Michaud,et al.  Sim2 contributes to neuroendocrine hormone gene expression in the anterior hypothalamus. , 2004, Molecular endocrinology.

[162]  C. Tohyama,et al.  Modulation of oestrogen receptor signalling by association with the activated dioxin receptor , 2003, Nature.

[163]  Dinshaw J. Patel,et al.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger , 2009, Nature.

[164]  J. Takahashi,et al.  Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists , 2012, Nature.

[165]  Thorsten Heinzel,et al.  A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.

[166]  R. Peterson,et al.  AHR signaling in prostate growth, morphogenesis, and disease. , 2009, Biochemical pharmacology.

[167]  Paolo Sassone-Corsi,et al.  The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control , 2008, Cell.

[168]  Ming-Feng Hou,et al.  Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. , 2005, Carcinogenesis.

[169]  Jared Rutter,et al.  Regulation of Clock and NPAS2 DNA Binding by the Redox State of NAD Cofactors , 2001, Science.

[170]  M. Southey,et al.  Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. , 2001, Cancer research.

[171]  L. Poellinger,et al.  A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice , 2004, Cancer Research.

[172]  Ian B. Dodd,et al.  Identification of residues in the N-terminal PAS domains important for dimerization of Arnt and AhR , 2011, Nucleic acids research.

[173]  S. Gery,et al.  The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. , 2006, Molecular cell.

[174]  Michele Pagano,et al.  SCFFbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins , 2007, Science.

[175]  Brian E. McIntosh,et al.  Mammalian Per-Arnt-Sim proteins in environmental adaptation. , 2010, Annual review of physiology.

[176]  Xiaoming Yang,et al.  Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis , 2008, Molecular Cancer Research.

[177]  U. Schibler,et al.  Poly(ADP-Ribose) Polymerase 1 Participates in the Phase Entrainment of Circadian Clocks to Feeding , 2010, Cell.

[178]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[179]  S. Antonarakis,et al.  Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. , 2000, Human molecular genetics.

[180]  J. Kutok,et al.  MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. , 2003, Cancer cell.

[181]  Achim Kramer,et al.  Unwinding the differences of the mammalian PERIOD clock proteins from crystal structure to cellular function , 2012, Proceedings of the National Academy of Sciences.